Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosis

被引:9
作者
Budin, Sofia [1 ,2 ,3 ]
Salmanton-Garcia, Jon [1 ,2 ,3 ]
Koehler, Philipp [1 ,2 ,3 ]
Stemler, Jannik [1 ,2 ,3 ,4 ]
Cornely, Oliver A. [1 ,2 ,3 ,4 ,5 ]
Mellinghoff, Sibylle C. [1 ,2 ,3 ,4 ]
机构
[1] Univ Cologne, Fac Med, Cologne, Germany
[2] Univ Hosp Cologne, Dept Internal Med 1, Excellence Ctr Med Mycol ECMM, Cologne, Germany
[3] Univ Hosp Cologne, Chair Translat Res, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany
[4] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
[5] Univ Hosp Cologne, Clin Trials Ctr Cologne ZKS Koln, Cologne, Germany
关键词
DIAGNOSIS; EPIDEMIOLOGY;
D O I
10.1093/jac/dkaa518
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate the diagnosis and treatment standards at the University Hospital of Cologne, Germany, by applying the EQUAL Aspergillosis Score to invasive pulmonary aspergillosis (IPA) patients. Methods: The charts of 103 patients with probable or proven IPA at the University Hospital of Cologne were reviewed and the score retrospectively applied to all patients. Results: Patients were stratified into two groups according to the underlying disease: a haematology group (n = 76, 73.8%) and a non-haematology group (n = 27, 26.2%). While the haematology group attained 67.8% of achievable score points (median: 15; IQR: 13-18; range: 8-25), the non-haematology group reached 48.4% (median: 12 points; IQR: 9-14; range: 4-18) (P < 0.001). Regarding diagnostics, haematological patients achieved 81.3% of achievable points (median: 7; IQR: 8-10; range: 3-13) and non-haematological 56.3% (median: 7; IQR: 5-9; range: 3-11). Concerning treatment, haematological patients gained 86.3% (median: 5; IQR: 5-5; range: 0-5) and non-haematological 68.1% (median: 5; IQR: 0-5; range: 0-5) of achievable points. Among the haematological patients with versus those without mould-active prophylaxis, 90 day mortality was 46.0% and 59.3% (P=0.004), respectively. Guideline adherent management of IPA was observed in 31.1% of cases (39.5% in haematological patients and 7.4% in non-haematological). Conclusions: The EQUAL Aspergillosis Score is more suitable for evaluation of management of haematological patients compared with those without such underlying disease. In both groups there was no correlation between score points and survival. Larger prospective studies may be suitable to correlate outcome and score. A revision of the score should be considered based on the data presented.
引用
收藏
页码:1070 / 1077
页数:8
相关论文
共 24 条
[1]   Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis [J].
Bassetti, M. ;
Giacobbe, D. R. ;
Grecchi, C. ;
Rebuffi, C. ;
Zuccaro, V. ;
Scudeller, L. .
JOURNAL OF INFECTION, 2020, 81 (01) :131-146
[2]   Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project [J].
Bassetti, Matteo ;
Scudeller, Luigia ;
Giacobbe, Daniele R. ;
Lamoth, Frederic ;
Righi, Elda ;
Zuccaro, Valentina ;
Grecchi, Cecilia ;
Rebuffi, Chiara ;
Akova, Murat ;
Alastruey-Izquierdo, Ana ;
Arikan-Akdagli, Sevtap ;
Azoulay, Elie ;
Blot, Stijn I. ;
Cornely, Oliver A. ;
Lass-Floerl, Cornelia ;
Koehler, Philipp ;
Cuenca-Estrella, Manuel ;
de Lange, Dylan W. ;
De Rosa, Francesco G. ;
De Waele, Jan J. ;
Dimopoulos, George ;
Garnacho-Montero, Jose ;
Hoenigl, Martin ;
Kanj, Souha S. ;
Maertens, Johan ;
Martin-Loeches, Ignacio ;
Munoz, Patricia ;
Kullberg, Bart J. ;
Agvald-Ohman, Christina ;
Poulakou, Garyphallia ;
Rello, Jordi ;
Sanguinetti, Maurizio ;
Taccone, Fabio S. ;
Timsit, Jean-Francois ;
Torres, Antoni ;
Vazquez, Jose A. ;
Calandra, Thierry .
MYCOSES, 2019, 62 (04) :310-319
[3]   ICU Admissions for Sepsis or Pneumonia in Australia and New Zealand in 2017 [J].
Burrell, Aidan ;
Huckson, Sue ;
Pilcher, David V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2138-2139
[4]   EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis [J].
Cornely, Oliver A. ;
Koehler, Philipp ;
Arenz, Dorothee ;
Mellinghoff, Sibylle C. .
MYCOSES, 2018, 61 (11) :833-836
[5]   Therapeutic outcome in invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :608-615
[6]   Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium [J].
Donnelly, J. Peter ;
Chen, Sharon C. ;
Kauffman, Carol A. ;
Steinbach, William J. ;
Baddley, John W. ;
Verweij, Paul E. ;
Clancy, Cornelius J. ;
Wingard, John R. ;
Lockhart, Shawn R. ;
Groll, Andreas H. ;
Sorrell, Tania C. ;
Bassetti, Matteo ;
Akan, Hamdi ;
Alexander, Barbara D. ;
Andes, David ;
Azoulay, Elie ;
Bialek, Ralf ;
Bradsher, Robert W., Jr. ;
Bretagne, Stephane ;
Calandra, Thierry ;
Caliendo, Angela M. ;
Castagnola, Elio ;
Cruciani, Mario ;
Cuenca-Estrella, Manuel ;
Decker, Catherine F. ;
Desai, Sujal R. ;
Fisher, Brian ;
Harrison, Thomas ;
Heussel, Claus Peter ;
Jensen, Henrik E. ;
Kibbler, Christopher C. ;
Kontoyiannis, Dimitrios P. ;
Kullberg, Bart-Jan ;
Lagrou, Katrien ;
Lamoth, Frederic ;
Lehrnbecher, Thomas ;
Loeffler, Jurgen ;
Lortholary, Olivier ;
Maertens, Johan ;
Marchetti, Oscar ;
Marr, Kieren A. ;
Masur, Henry ;
Meis, Jacques F. ;
Morrisey, C. Orla ;
Nucci, Marcio ;
Ostrosky-Zeichner, Luis ;
Pagano, Livio ;
Patterson, Thomas F. ;
Perfect, John R. ;
Racil, Zdenek .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) :1367-1376
[7]  
Fabri MG, 2019, U HOSP COLOGNE TREAT
[8]   Invasive Aspergillosis in Patients Treated With Ibrutinib [J].
Fuerstenau, Moritz ;
Simon, Florian ;
Cornely, Oliver A. ;
Hicketier, Tillman ;
Eichhorst, Barbara ;
Hallek, Michael ;
Mellinghoff, Sibylle C. .
HEMASPHERE, 2020, 4 (02)
[9]   Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis [J].
Hoenigl, M. ;
Prattes, J. ;
Spiess, B. ;
Wagner, J. ;
Prueller, F. ;
Raggam, R. B. ;
Posch, V. ;
Duettmann, W. ;
Hoenigl, K. ;
Woelfler, A. ;
Koidl, C. ;
Buzina, W. ;
Reinwald, M. ;
Thornton, C. R. ;
Krause, R. ;
Buchheidt, D. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (06) :2039-2045
[10]   The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1→3)-β-D-Glucan, and Consequences of Delayed Antifungal Therapy [J].
Hope, William W. ;
Petraitis, Vidmantas ;
Petraitiene, Ruta ;
Aghamolla, Tamarra ;
Bacher, John ;
Walsh, Thomas J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) :4879-4886